T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Airlines Group
AAL
|
+$1.21B |
| 2 |
RTX Corp
RTX
|
+$1.14B |
| 3 |
PepsiCo
PEP
|
+$1.12B |
| 4 |
ASML
ASML
|
+$817M |
| 5 |
Wynn Resorts
WYNN
|
+$798M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.24B |
| 2 |
Mastercard
MA
|
+$1.08B |
| 3 |
Qualcomm
QCOM
|
+$972M |
| 4 |
eBay
EBAY
|
+$898M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$748M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.21% |
| 2 | Consumer Discretionary | 13.72% |
| 3 | Financials | 13.22% |
| 4 | Industrials | 12.45% |
| 5 | Technology | 10.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KW
1426
DELISTED
Kennedy-Wilson Holdings
KW
| $5.04M | ﹤0.01% |
223,943
+10,900
| +5% | +$258K |
|
|
WFT
1427
DELISTED
Weatherford International plc
WFT
| $5.03M | ﹤0.01% |
289,630
+206,630
| +249% | +$3.17M |
|
1428
Expro Ltd
XPRO
$2.12B
| $4.97M | ﹤0.01% |
33,450
-283
| -0.8% | -$40.3K |
|
|
DRNA
1429
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $4.88M | ﹤0.01% |
+172,800
| New | +$6.42M |
|
1430
ICU Medical
ICUI
$4.56B
| $4.85M | ﹤0.01% |
81,000
+900
| +1% | +$55.4K |
|
|
DISH
1431
DELISTED
DISH Network Corp.
DISH
| $4.84M | ﹤0.01% |
77,823
+3,203
| +4% | +$186K |
|
1432
Gran Tierra Energy
GTE
$332M
| $4.77M | ﹤0.01% |
63,786
-2,000
| -3% | -$146K |
|
1433
Knowles
KN
$3.28B
| $4.7M | ﹤0.01% |
+148,966
| New | +$4.62M |
|
1434
Globus Medical
GMED
$11.5B
| $4.69M | ﹤0.01% |
176,549
-363,270
| -67% | -$8.63M |
|
|
HGG
1435
DELISTED
hhgregg Inc.
HGG
| $4.69M | ﹤0.01% |
488,040
-1,670
| -0.3% | -$16.7K |
|
1436
Ulta Beauty
ULTA
$21.9B
| $4.67M | ﹤0.01% |
47,946
-26,204
| -35% | -$2.36M |
|
|
TAST
1437
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $4.61M | ﹤0.01% |
643,577
| – | – |
|
|
MBT
1438
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $4.58M | ﹤0.01% |
262,100
-88,000
| -25% | -$1.57M |
|
1439
HF Sinclair
DINO
$16.5B
| $4.33M | ﹤0.01% |
91,092
+140
| +0.2% | +$6.62K |
|
|
PZN
1440
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $4.33M | ﹤0.01% |
367,790
+18,200
| +5% | +$206K |
|
1441
Dana Inc
DAN
$3.26B
| $4.3M | ﹤0.01% |
184,700
-56,600
| -23% | -$1.17M |
|
1442
Myriad Genetics
MYGN
$297M
| $4.29M | ﹤0.01% |
125,600
-800
| -0.6% | -$24.8K |
|
1443
Erie Indemnity
ERIE
$13.4B
| $4.26M | ﹤0.01% |
61,100
| – | – |
|
|
ECHO
1444
EchoStar
ECHO
$26.5B
| $4.26M | ﹤0.01% |
110,473
+96,623
| +698% | +$3.82M |
|
1445
Accuray
ARAY
$33.6M
| $4.19M | ﹤0.01% |
436,640
+240
| +0.1% | +$2.27K |
|
|
XRM
1446
DELISTED
Xerium Technologies Inc (new)
XRM
| $4.17M | ﹤0.01% |
+260,000
| New | +$4.24M |
|
1447
Advance Auto Parts
AAP
$3.42B
| $4.12M | ﹤0.01% |
32,580
-5,855
| -15% | -$710K |
|
1448
Monolithic Power Systems
MPWR
$67.8B
| $4.1M | ﹤0.01% |
105,800
| – | – |
|
|
MXIM
1449
DELISTED
Maxim Integrated Products
MXIM
| $4.1M | ﹤0.01% |
123,721
-2,900
| -2% | -$89.1K |
|
1450
Children's Place
PLCE
$53.8M
| $4.08M | ﹤0.01% |
81,950
-2,200
| -3% | -$117K |
|
Similar funds
T. Rowe Price Associates's Q1 2014 Portfolio in Review
As of Q1 2014, T. Rowe Price Associates held 2,567 positions worth $445B, up 2% from $436B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q1 2014 filing shows 89 new, 904 increased, 825 reduced and 68 closed positions. Its largest new stake was Liberty Global Class C: 13,695,496 shares worth $451M. The largest sale was Apple, an estimated $1.24B.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2014 buy was Liberty Global Class C: 13,695,496 shares worth $451M.
- T. Rowe Price Associates added most to American Airlines Group in Q1 2014, an estimated $1.21B increase.
- T. Rowe Price Associates's biggest Q1 2014 reduction was Apple, cutting an estimated $1.24B.
- T. Rowe Price Associates fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $200M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $445B portfolio in Q1 2014.
- T. Rowe Price Associates opened 89 new positions and closed 68 in Q1 2014.
- T. Rowe Price Associates's portfolio value rose 2% quarter-over-quarter to $445B.
Based on T. Rowe Price Associates's 13F filing for Q1 2014, filed 15 May 2014.